2021
DOI: 10.7759/cureus.16045
|View full text |Cite
|
Sign up to set email alerts
|

Subacute Thyroiditis After Receiving the Adenovirus-Vectored Vaccine for Coronavirus Disease (COVID-19)

Abstract: Since the emergence of the coronavirus disease pandemic, several effective vaccines have been introduced. These vaccines work through several different immunogenic pathways to produce effective immunity. There have been a number of reports of patients developing subacute thyroiditis and thyroid dysfunction after receiving the coronavirus (COVID-19) vaccine. This paper presents a case of a female patient who developed subacute thyroiditis soon after receiving the adenovirus-vectored COVID-19 vaccine. The patien… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
63
0
2

Year Published

2021
2021
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 68 publications
(65 citation statements)
references
References 18 publications
0
63
0
2
Order By: Relevance
“…Two more cases have been described after vaccination with the mRNA-based Comirnaty (BioNTech, Fosun Pharma, Pfizer, Germany, and USA) ( 9 , 12 ). Very recently Oyibo ( 11 ) presented a case of subacute thyroiditis following SARS-CoV-2 vaccination with Vaxzevria (AstraZeneca; Sweden). One of the two cases presented here also developed subacute thyroiditis following the vector-based vaccine Vaxzevria (AstraZeneca; Sweden) while the other case is the first known patient that developed subacute thyroiditis following the mRNA-based vaccine Spikevax (Moderna Biotech, Spain).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Two more cases have been described after vaccination with the mRNA-based Comirnaty (BioNTech, Fosun Pharma, Pfizer, Germany, and USA) ( 9 , 12 ). Very recently Oyibo ( 11 ) presented a case of subacute thyroiditis following SARS-CoV-2 vaccination with Vaxzevria (AstraZeneca; Sweden). One of the two cases presented here also developed subacute thyroiditis following the vector-based vaccine Vaxzevria (AstraZeneca; Sweden) while the other case is the first known patient that developed subacute thyroiditis following the mRNA-based vaccine Spikevax (Moderna Biotech, Spain).…”
Section: Discussionmentioning
confidence: 99%
“…These alterations might be independent of the mechanism of action of the SARS-CoV-2 vaccination as described patients received mRNA-based vaccines as well as inactivated SARS-CoV-2 and vector-based vaccines. A possible cross-reactivity between thyroid cell antigens and the spike protein of the coronavirus that is produced by the mRNA vaccines has also been assumed ( 11 , 18 ). Furthermore, development of subacute thyroiditis following other kinds of vaccinations as influenza or hepatitis B has also been rarely described in the literature.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Oyibo S.O. reports a case of a 55-year-old female with SAT some days subsequent to administration of the adenovirus-vectored COVID-19 vaccine (Oxford-AstraZeneca) [ 5 ]. Tekin et al describe the case of a 67-year-old male patient presenting with SAT several days after receiving the second dose of Coronavac [ 6 ].…”
Section: Casementioning
confidence: 99%